Evolent Health (EVH) Depreciation & Amortization - Total (2015 - 2026)

Evolent Health has reported Depreciation & Amortization - Total for 12 years, with the latest figure at $6.3 million in Q2 2026.

• On a quarterly basis, Depreciation & Amortization - Total fell 1.56% year-over-year to $6.3 million in Q2 2026; TTM through Jun 2026 was $25.2 million, a 11.89% decrease from a year earlier, with the FY2025 full-year figure at $26.3 million, down 13.2% from the prior year.
• Depreciation & Amortization - Total was $6.3 million for Q2 2026 at Evolent Health, roughly flat from $6.3 million in the prior quarter.
• The five-year high for Depreciation & Amortization - Total was $8.9 million in Q4 2022, with the low at $6.3 million in Q3 2025.
• Average Depreciation & Amortization - Total over 5 years is $7.4 million, with a median of $7.6 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization - Total climbed 14.1% in 2022, then declined 18.99% in 2025.
• Over 5 years, Depreciation & Amortization - Total stood at $8.9 million in 2022, then decreased by 14.61% to $7.6 million in 2023, then decreased by 2.63% to $7.4 million in 2024, then slipped by 14.86% to $6.3 million in 2025, then changed by 0.0% to $6.3 million in 2026.
• The last three Depreciation & Amortization - Total figures came in at $6.3 million (Q2 2026), $6.3 million (Q1 2026), and $6.3 million (Q4 2025), per Business Quant data.